等离子体电池
生发中心
B细胞
生物
CD19
交易激励
细胞分化
细胞生物学
转录因子
幼稚B细胞
分子生物学
BCL6公司
心理压抑
抗体
CD40
基因表达
流式细胞术
体外
基因
免疫学
遗传学
细胞毒性T细胞
作者
Heike Schmidlin,Sean A. Diehl,Maho Nagasawa,Ferenc A. Scheeren,Remko Schotte,Christel H. Uíttenbogaart,Hergen Spits,Bianca Blom
出处
期刊:Blood
[Elsevier BV]
日期:2008-09-01
卷期号:112 (5): 1804-1812
被引量:64
标识
DOI:10.1182/blood-2008-01-136440
摘要
The terminal differentiation of B cells into antibody-secreting plasma cells is tightly regulated by a complex network of transcription factors. Here we evaluated the role of the Ets factor Spi-B during terminal differentiation of human B cells. All mature tonsil and peripheral blood B-cell subsets expressed Spi-B, with the exception of plasma cells. Overexpression of Spi-B in CD19(+) B cells inhibited, similar to the known inhibitor BCL-6, the expression of plasma cell-associated surface markers and transcription factors as well as immunoglobulin production, ie, in vitro plasma cell differentiation. The arrest in B-cell differentiation enforced by Spi-B was independent of the transactivation domain, but dependent on the Ets-domain. By chromatin immunoprecipitation and assays using an inducible Spi-B construct BLIMP1 and XBP-1 were identified as direct target genes of Spi-B mediated repression. We propose a novel role for Spi-B in maintenance of germinal center and memory B cells by direct repression of major plasma cell factors and thereby plasma cell differentiation.
科研通智能强力驱动
Strongly Powered by AbleSci AI